Blockbusters Lipitor and Plavix disappear from list due to patent expirations
It’s not the most expensive drug, but according to consensus sales forecasts from financial analysts compiled by Thomson Reuters, Roche’s cancer drug Avastin will secure the spot for the world’s top-selling drug in 2014, with a forecasted $8.9B in sales. Roche dominates the list with three drugs—joining Avastin are cancer drugs Rituxan and Herceptin.
World’s Top-Selling Drugs in 2014
1. Avastin (Roche), $8.9B - cancer
2. Humira (Abbott), $8.5B - arthritis
3. Enbrel (Pfizer/Amgen), $8B - arthritis
4. Crestor (AstraZeneca), $7.7B - cholesterol
5. Remicade (Merck/J&J), $7.6B - arthritis
6. Rituxan (Roche), $7.4B - cancer
7. Lantus (Sanofi-Aventis), $7.1B - diabetes
8. Advair (GlaxoSmithKline), $6.8B - asthma/COPD
9. Herceptin (Roche), $6.4B - cancer
10. NovoLog (Novo Nordisk), $5.7B - diabetes
Topping the 2010 forecast, also compiled by Reuters, is Pfizer’s Lipitor, with an estimated $11.7B in sales. The cholesterol drug was the seventh most prescribed drug in the US in 2009, according to IMS Health.
Sanofi-Aventis and Bristol Myers Squibb’s Plavix snagged second place on Reuters’ 2010 list of top sellers, with an estimated $9.6B in sales. The anticlotting agent, along with Lipitor and Novartis’ blood pressure medication Diovan, are the only three that appear on the 2010 list but not on the 2014 list. The patents for Lipitor and Plavix expire next year, while the patent for Diovan expires in 2012.
Trending Data & Response Plans in the Cleanroom Setting
April 30th 2025Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.
ABM’s Digital Solution for Good Manufacturing Practices
April 30th 2025Learn how our digital GMP solution ensures compliance with high regulatory standards, and offers faster, more accurate data access. By utilizing a mobile app for data collection and a management dashboard for task visibility and validation, it goes beyond traditional paper methods to meet growing industry needs.